专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2017115467A1 NANOPARTICLE-CONDUCTING POLYMER COMPOSITE FOR USE IN ORGANIC ELECTRONICS 审中-公开
标题翻译：纳米粒子导电聚合物复合材料用于有机电子学
公开(公告)号：WO2017115467A1
公开(公告)日：2017-07-06
申请号：PCT/JP2016/005258
申请日：2016-12-28
申请人： NISSAN CHEMICAL INDUSTRIES, LTD.
发明人： SIMS, Marc , LI, Sergey B. , GAUDIN, Olivier , PANNONE, Michael , SHEINA, Elena
IPC分类号： H01L51/50 , C08K3/10 , C08K3/20 , C08L65/00 , C09D11/102 , C09D11/106 , H01L51/46
CPC分类号： C08K3/36 , C08G2261/1424 , C08G2261/1452 , C08G2261/3223 , C08G2261/95 , C08K3/20 , C08K2201/011 , C09D11/102 , C09D11/106 , H01L51/0036 , H01L51/5056 , H01L51/5088 , H01L2251/5369 , C08L65/00
摘要： Described herein are nanoparticle-conductive polymer composite films containing a polythiophene having a repeating unit complying with formula (I) described herein and one or more metallic or metalloid nanoparticles and their use, for example, in organic electronic devices. The present disclosure also concerns the use of one or more metallic or metalloid nanoparticles in organic electronic devices to improve light outcoupling leading to increased efficiency, to improve color saturation, and to improve color stability.
摘要翻译：本文描述了纳米粒子导电聚合物复合膜，其包含具有符合本文所述的式（I）的重复单元的聚噻吩和一种或多种金属或类金属纳米粒子及其在例如有机电子中的用途设备。本公开还涉及一种或多种金属或类金属纳米颗粒在有机电子器件中的用途，以改善光外耦合，导致效率提高，改善颜色饱和度并改善颜色稳定性。

2. 发明申请

WO2007100161A1 METHOD FOR PREFERENTIAL PRODUCTION OF GEOMETRIC ISOMERS AND ISOLATION METHOD 审中-公开
标题翻译：优选生产几何异构体和分离方法的方法
公开(公告)号：WO2007100161A1
公开(公告)日：2007-09-07
申请号：PCT/JP2007/054623
申请日：2007-03-02
申请人： NISSAN CHEMICAL INDUSTRIES, LTD. , KUSUOKA, Yoshiyuki , SUZUKI, Hideaki , TANAKA, Norio
发明人： KUSUOKA, Yoshiyuki , SUZUKI, Hideaki , TANAKA, Norio
IPC分类号： C07D277/32 , A01N43/78
CPC分类号： A01N43/78 , C07D277/32
摘要： A method for the preferential production of the Z form of a compound represented by the formula (5) [in the formula (5), Q, A and B have the same meanings as stated below], by reacting an acrylonitrile compound represented by the formula (1) [in the formula (1), Q represents unsubstituted or substituted phenyl or heterocyclyl, in particular 4-thiazolyl, 1- or 3-pyrazolyl, 1,3-oxazolyl-4-yl, phenyl, pyridyl or the like, A represents pyrazolyl, thiazolyl or the like, and B represents alkylcarbonyl or the like] with a compound represented by formula (3) [in the formula (3), B represents alkylcarbonyl or the like] or a compound represented by the formula (4) [in the formula (4), B has the same meaning as aforesaid], in the presence of a compound represented by the formula (2) [in the formula (2) R represents H, dimetylamino and the like], and a method for the isolation of geometric isomers, wherein, by dissolving or suspending a geometric isomer mixture of an acrylonitrile compound represented by the formula (5) in an alcohol or a solvent containing an alcohol, the E form is preferentially decomposed and the Z form is isolated, and wherein the decomposition product can be simply recovered by normal operations and reutilized.
摘要翻译：优选制备由式（5）[式（5）中Q，A和B表示的化合物的Z形式的Z形式的方法具有如下所述的相同含义]，通过使由式（1）[式（1）中，Q表示未取代或取代的苯基或杂环基，特别是4-噻唑基，1-或3-吡唑基，1,3-恶唑基-4-基，苯基，吡啶基等与式（3）表示的化合物[式（3）中，B表示烷基羰基等]或式（I）表示的化合物，A表示吡唑基，噻唑基等，B表示烷基羰基等] 4）[式（4）中，B具有与上述相同的含义]，在式（2）表示的化合物[式（2）中R表示H，二甲基氨基等]的存在下，分离几何异构体的方法，其中通过溶解或悬浮丙烯腈化合物代表的几何异构体混合物通过式（5）在醇或含有醇的溶剂中，E型优先分解，Z形分离，其中分解产物可以通过正常操作简单回收并重新利用。

3. 发明申请

WO2003000675A1 SUBSTITUTED BENZOPYRAN DERIVATIVES AGAINST ARRHYTHMIA 审中-公开
标题翻译：取代苯甲酸衍生物抗ARRHYTHMIA
公开(公告)号：WO2003000675A1
公开(公告)日：2003-01-03
申请号：PCT/JP2002/006012
申请日：2002-06-17
申请人： NISSAN CHEMICAL INDUSTRIES, LTD. , OHARA, Yoshio , OHRAI, Kazuhiko , YANAGIHARA, Kazufumi , SHIGETA, Yukihiro , TSUKAGOSHI, Toru , YAMASHITA, Toru
发明人： OHARA, Yoshio , OHRAI, Kazuhiko , YANAGIHARA, Kazufumi , SHIGETA, Yukihiro , TSUKAGOSHI, Toru , YAMASHITA, Toru
IPC分类号： C07D311/68
CPC分类号： C07D311/68
摘要： This invention relates to benzopyran derivatives of the formula (1) or the formula (2) wherein R 1 and R 2 represent independently of each other hydrogen atom or C 1-6 alkyl group, R 3 represents hydroxyl group or C 1-6 alkylcarbonyloxy group, R 4 represents hydrogen atom or C 1-6 alkyl group, R 5 represents C 1-6 alkyl group substituted with C 6-14 aryl group or heteroaryl group, R 6 represents C 1-6 alkyl group, C 1-6 alkoxy group, halogen atom, nitro group, C(O)NH 2 , C(O)NHR 8 or C(O)NR 8 R 9 , or pharmaceutically acceptable salts thereof. These compounds are useful as an antiarrhythmic agent.
摘要翻译：本发明涉及式（1）或式（2）的苯并吡喃衍生物，其中R 1和R 2彼此独立地表示氢原子或C 1-6烷基，R 3表示羟基或C 1 -6烷基羰基氧基，R 4表示氢原子或C 1-6烷基，R 5表示被C 6-14芳基或杂芳基取代的C 1-6烷基，R 6表示C 1-6烷基，C 1-6烷氧基，卤素原子，硝基，C（O）NH 2，C（O）NHR 8或C（O）NR 8 R 9或其药学上可接受的盐。这些化合物可用作抗心律失常药。

4. 发明申请

WO1997044377A1 MELAMINE POLYMETAPHOSPHATE AND PROCESS FOR ITS PRODUCTION 审中-公开
标题翻译：聚甲基丙烯酸甲酯及其生产工艺
公开(公告)号：WO1997044377A1
公开(公告)日：1997-11-27
申请号：PCT/JP1997001712
申请日：1997-05-21
申请人： NISSAN CHEMICAL INDUSTRIES, LTD. , SUZUKI, Keitaro , SHISHIDO, Kouji , SHINDO, Masuo
发明人： NISSAN CHEMICAL INDUSTRIES, LTD.
IPC分类号： C08G79/02
CPC分类号： C08K5/34928 , C08G79/02 , C08K5/529
摘要： A melamine polymetaphosphate having a solubility of from 0.01 to 0.10 g/100 ml in water at 25 DEG C, a pH of from 2.5 to 4.5 in the form of a 10 wt.% aqueous slurry at 25 DEG C and a melamine content of from 1.0 to 1.1 mol per mol of phosphorus atom. A process for producing such a melamine polymetaphosphate, which comprises the following steps (a) and (b): (a) a step of mixing melamine, urea and an aqueous orthophosphoric acid solution containing at least 40 wt.% of orthophosphoric acid, in such a ratio that melamine is from 1.0 to 1.5 mol per mol of orthophosphoric acid and urea is from 0.1 to 1.5 mol per mol of orthophosphoric acid, at a temperature of from 0 to 140 DEG C, to form a reaction mixture, and stirring the reaction mixture at a temperature of from 0 to 140 DEG C, while removing water, to obtain a powdery product of a double salt of orthophosphoric acid with melamine and urea; and (b) a step of calcining the powdery product obtained in step (a) at a temperature of from 240 to 340 DEG C for from 0.1 to 30 hours, while preventing agglomeration, to obtain a melamine polymetaphosphate.
摘要翻译：在25℃下在水中溶解度为0.01至0.10g / 100ml，pH为2.5至4.5，在25℃下为10重量％含水浆料形式的三聚氰胺聚偏磷酸钠，三聚氰胺含量为每摩尔磷原子为1.0-1.1摩尔。一种制备这种三聚氰胺聚偏磷酸盐的方法，其包括以下步骤（a）和（b）：（a）将含有至少40重量％正磷酸的三聚氰胺，尿素和正磷酸水溶液混合在三聚氰胺的摩尔比为每摩尔正磷酸为1.0〜1.5摩尔，尿素为0.1〜1.5摩尔/升正磷酸，温度为0〜140℃，形成反应混合物，搅拌反应混合物在0-140℃的温度下，同时除去水，得到正磷酸的双重盐与三聚氰胺和尿素的粉末状产物; 和（b）在240〜340℃的温度下煅烧步骤（a）中得到的粉末状产物0.1〜30小时，同时防止团聚，得到三聚氰胺聚偏磷酸酯的工序。

5. 发明申请

WO1997034610A1 PROCESS FOR PRODUCING EFONIDIPINE HYDROCHLORIDE PREPARATIONS 审中-公开
标题翻译：生产氟尼泊替氯化氢制剂的方法
公开(公告)号：WO1997034610A1
公开(公告)日：1997-09-25
申请号：PCT/JP1997000842
申请日：1997-03-17
申请人： NISSAN CHEMICAL INDUSTRIES, LTD. , ZERIA PHARMACEUTICAL CO., LTD. , MIYAMOTO, Misao , ODA, Toshihisa , BUNRIN, Toyohiko , OKABE, Toshio , NISHIYAMA, Tetsuyuki
发明人： NISSAN CHEMICAL INDUSTRIES, LTD. , ZERIA PHARMACEUTICAL CO., LTD.
IPC分类号： A61K31/675
CPC分类号： A61K9/146 , A61K9/145 , A61K9/1617 , A61K9/1652 , A61K31/66 , A61K31/675
摘要： The present invention can form an amorphous solid dispersion of efonidipine hydrochloride having a high intestinal absorbability which can be formed by subjecting a mixture containing efonidipine hydrochloride of formula (I), hydroxypropylmethylcellulose acetate succinate and optionally a thermostabilizer to a step A of heat treatment at from 85 to 140 DEG C or mechanochemical treatment at from 0 to 140 DEG C, and then to a step B of dipping treatment into a water-containing solution, impregnation treatment with a water-containing solution or contacting treatment with a water vapor-containing gas; or treating the above-mentioned mixture with a hot steam at from 100 to 140 DEG C and a high pressure. Further, in the above-mentioned step A, the mixture is subjected to high frequency heating, making it possible to give a solid dispersion of efonidipine hydrochloride having a high intestinal absorbability without using the step B. This process is quite advantageous in the production in that the use of an organic solvent is not required.
摘要翻译：本发明可以形成具有高肠吸收能力的盐酸依替地平盐酸盐的无定形固体分散体，其可以通过使式（I）的依地尼地平盐酸盐，乙酸琥珀酸羟丙基甲基纤维素和任选的热稳定剂的混合物进行热处理步骤A 85〜140℃，0〜140℃下进行机械化学处理，然后进行浸渍处理至含水溶液的工序B，用含水溶液进行浸渍处理或与含有水蒸汽的气体进行接触处理 ; 或用100〜140℃的热蒸汽和高压处理上述混合物。此外，在上述步骤A中，将混合物进行高频加热，使得可以在不使用步骤B的情况下得到具有高肠吸收能力的盐酸依替地平的固体分散体。该方法在生产中是非常有利的不需要使用有机溶剂。

6. 发明申请

WO1997031908A1 THIFLUZAMIDE WITH ENHANCED POTENCY 审中-公开
标题翻译：具有增强光泽度的噻菌胺
公开(公告)号：WO1997031908A1
公开(公告)日：1997-09-04
申请号：PCT/JP1997000613
申请日：1997-02-28
申请人： NISSAN CHEMICAL INDUSTRIES, LTD. , ROHM AND HAAS COMPANY , HAYAKAWA, Norihito , BABA, Masatoshi , SUWA, Norihiro , YAMAGISHI, Kazuhiro
发明人： NISSAN CHEMICAL INDUSTRIES, LTD. , ROHM AND HAAS COMPANY
IPC分类号： C07D277/56
CPC分类号： C07D277/56 , A01N43/78
摘要： Thifluzamide with its crystal form dislocated, a process for producing the same, and a pesticidal composition containing the same as the active ingredient. The thifluzamide has an increased rate of dissolution into water and the composition has an enhanced potency.
摘要翻译：其晶体形式脱落的噻吗喃酰胺，其制造方法和含有该活性成分的杀虫剂组合物。 thifluzamide具有增加的水溶解速率，并且组合物具有增强的效力。

7. 发明申请

WO1997023627A1 RICE NADH-DEPENDENT REDUCTASE, GENE THEREFOR, AND USE THEREOF 审中-公开
标题翻译：赖氨酸依赖性还原酶，其基因及其用途
公开(公告)号：WO1997023627A1
公开(公告)日：1997-07-03
申请号：PCT/JP1995002641
申请日：1995-12-22
申请人： NISSAN CHEMICAL INDUSTRIES, LTD. , UCHIMIYA, Hirofumi , FUSHIMI, Takaomi , KUDOU, Ume , TAGAWA, Michito
发明人： NISSAN CHEMICAL INDUSTRIES, LTD.
IPC分类号： C12N15/53
CPC分类号： C12N9/0036 , C12N9/0004 , C12N15/8282
摘要： A gene for rice NADH-dependent reductase or a modification thereof; a rice NADH-dependent reductase or an analogue thereof; a DNA or expression vector containing the gene or modification thereof and capable of expressing in microorganisms or plant cells; and a plant transformed by the expression vector or seeds thereof. By cultivating the transformed plant, it is possible to protect the plant from damages caused by disease bacteria.
摘要翻译：水稻NADH依赖性还原酶的基因或其修饰; 水稻NADH依赖性还原酶或其类似物; 含有该基因或其修饰并能够在微生物或植物细胞中表达的DNA或表达载体; 和由表达载体或其种子转化的植物。通过培育转化植物，可以保护植物免受疾病细菌的损害。

8. 发明申请

WO1997023209A1 THERAPEUTIC AGENT FOR CARDIAC FAILURE 审中-公开
标题翻译：治疗失败的治疗剂
公开(公告)号：WO1997023209A1
公开(公告)日：1997-07-03
申请号：PCT/JP1996003761
申请日：1996-12-24
申请人： NISSAN CHEMICAL INDUSTRIES, LTD. , TANIKAWA, Keizo , OHRAI, Kazuhiko , SATO, Masayuki , YAMASHITA, Toru
发明人： NISSAN CHEMICAL INDUSTRIES, LTD.
IPC分类号： A61K31/35
CPC分类号： C07D311/68 , A61K31/353 , A61K31/397 , A61K31/4025 , A61K31/453 , A61K31/55
摘要： A therapeutic agent for cardiac failure comprising as the active ingredient either a benzopyran derivative represented by general formula (I) or a pharmacologically acceptable salt thereof, wherein R and R each independently represent hydrogen, halogeno, nitro, cyano, amino, C1-6 alkylcarbonylamino, etc.; R and R each independently represents hydrogen, C1-6 alkyl, or phenyl, or R and R are bonded together to form C3-6 cycloalkyl in cooperation with the carbon atom bonded thereto; R represents hydroxy, C1-6 alkoxy, or C1-6 alkylcarbonyloxy, or R is bonded to R to form a bond; R represents hydrogen, or R is bonded to R to form a bond; and R and R each independently represent hydrogen or C1-6 alkyl, or R and R are bonded together to form pyrrolidinyl, imidazolidinyl, pyrazolidinyl, piperidyl, piperazinyl, etc. in cooperation with the nitrogen atom bonded thereto, or R and R are bonded together to form, in cooperation with the nitrogen atom bonded thereto, pyrrole ring optionally substituted with R (where R has the same meaning as R ).
摘要翻译：一种用于心力衰竭的治疗剂，其包含作为活性成分的通式（I）表示的苯并吡喃衍生物或其药理学上可接受的盐，其中R 1和R 2各自独立地表示氢，卤素，硝基，氰基，氨基，C 1-6烷基羰基氨基等; R 3和R 4各自独立地表示氢，C 1-6烷基或苯基，或者R 3和R 4与键合的碳原子一起形成C 3-6环烷基; R 5表示羟基，C 1-6烷氧基或C 1-6烷基羰基氧基，或R 5与R 6结合形成键; R 6表示氢，或R 6与R 5键合形成键; R 7和R 8各自独立地表示氢或C 1-6烷基，或者R 7和R 8结合在一起形成吡咯烷基，咪唑烷基，吡唑烷基，哌啶基，哌嗪基等，与与其键合的氮原子或R 7和R 8键合在一起，以与其键合的氮原子一起形成任选被R 9取代的吡咯环（其中R 9具有相同的含义作为R 1）。

9. 发明申请

WO1997013757A1 PYRAZOLONE DERIVATIVES 审中-公开
标题翻译：吡唑啉酮衍生物
公开(公告)号：WO1997013757A1
公开(公告)日：1997-04-17
申请号：PCT/JP1996002944
申请日：1996-10-11
申请人： NISSAN CHEMICAL INDUSTRIES, LTD. , TANIKAWA, Keizo , MATSUMOTO, Takashi , NAKAMURA, Masumi , ASADA, Yasunori , SHUDO, Norimasa
发明人： NISSAN CHEMICAL INDUSTRIES, LTD.
IPC分类号： C07D231/22
CPC分类号： C07D231/12 , C07D231/14 , C07D231/20 , C07D231/22 , C07D401/04 , C07D401/06 , C07D401/14 , C07D403/04
摘要： Pyrazolone derivatives represented by general formula (I) or salts thereof which have antiplatelet aggregation effects and thus are useful as a preventive or remedy for various thrombotic diseases. In said formula (I) X and X represents (a), wherein A represents cyano, cyano(C1-4 alkyl), amino, amino-(C1-4 alkyl), amidino, guanidino, etc.; and R and R independently represents each hydrogen, halogeno, C1-6 alkyl, etc.; another of X and X represents C1-6 alkyl, C3-6 alkenyl, aryl(C1-4 alkyl) or aryl; one of Y and Y represents (b), wherein Q represents oxygen or sulfur; Z represents oxygen, -NR - or -CHR -; Z represents cyclic C3-7 alkylene, C1-3 alkylene, -CH2CO-, -CH2CH2CO-, etc.; Z represents oxygen, sulfur, sulfinyl, sulfonyl, etc.; Z represents C1-3 alkylene, etc.; and Z represents carboxyl, etc.; and another of Y and Y represents D-E-, wherein E represents a bond, C1-4 alkylene, phenylene, etc.; and D represents hydrogen, C1-6 alkyl, etc.
摘要翻译：具有抗血小板聚集效应的由通式（I）表示的吡唑啉酮衍生物或其盐，因此可用作各种血栓形成疾病的预防或治疗。在所述式（I）中，X 1和X 2代表（a），其中A表示氰基，氰基（C 1-4烷基），氨基，氨基 - （C 1-4烷基），脒基，胍基等 ; R 1和R 2各自独立地表示氢，卤代C 1-6烷基等; X 1和X 2中的另一个表示C 1-6烷基，C 3-6烯基，芳基（C 1-4烷基）或芳基; Y 1和Y 2中的一个表示（b），其中Q表示氧或硫; Z 1表示氧，-NR 7 - 或-CHR 7 - ; Z 2表示环状C 3-7亚烷基，C 1-3亚烷基，-CH 2 CO-，-CH 2 CH 2 CO-等; Z 3表示氧，硫，亚磺酰基，磺酰基等; Z 4表示C 1-3亚烷基等。 Z 5表示羧基等。 Y 1和Y 2中的另一个表示D-E-，其中E表示键，C 1-4亚烷基，亚苯基等; D表示氢，C 1-6烷基等。

10. 发明申请

WO1996028250A1 TITANIUM CATALYST, ORGANOTITANIUM REACTION REAGENT, PROCESSES FOR PRODUCING THESE, AND METHOD OF REACTION USING THESE 审中-公开
标题翻译：钛催化剂，有机反应试剂，生产这些试剂的方法和使用这些反应的反应方法
公开(公告)号：WO1996028250A1
公开(公告)日：1996-09-19
申请号：PCT/JP1996000578
申请日：1996-03-08
申请人： NISSAN CHEMICAL INDUSTRIES, LTD. , SATO, Fumie
发明人： NISSAN CHEMICAL INDUSTRIES, LTD.
IPC分类号： B01J31/22
CPC分类号： C07F7/083 , B01J31/0211 , B01J31/0212 , B01J31/0252 , B01J31/122 , B01J2231/32 , B01J2231/324 , B01J2231/341 , C07B37/02 , C07B41/02 , C07B43/04 , C07B2200/07 , C07C29/00 , C07C29/38 , C07C45/49 , C07C45/54 , C07C49/24 , C07C49/753 , C07C49/835 , C07C209/60 , C07C209/66 , C07C209/68 , C07C213/02 , C07C2601/02 , C07C2601/06 , C07C2601/08 , C07C2601/14 , C07C2601/18 , C07C2602/10 , C07C2602/18 , C07C2602/26 , C07C2603/06 , C07D207/20 , C07D307/28 , C07D307/58 , C07D309/32 , C07C211/40 , C07C211/42 , C07C215/24 , C07C215/30 , C07C33/02 , C07C33/025 , C07C33/042 , C07C33/16 , C07C33/28 , C07C33/30 , C07C33/36 , C07C33/38 , C07C33/483 , C07C33/486 , C07C35/04 , C07C35/06 , C07C35/27 , C07C35/36 , C07C35/37
摘要： A titanium catalyst for use in the reaction between unsaturated carbon-to-carbon bonds and a compound having an electrophilic functional group or an electrophilic agent, which catalyst comprises a titanium compound represented by the general formula (1): TiX X X X (wherein X , X , X and X represent each independently halogeno, C1-C20 alkoxy, aralkyloxy, aryloxy or -NRxRy (wherein Rx and Ry represent each independently C1-C20 alkyl or aralkyl), or alternatively any of X , X , X and X may form a ring together with the other of them) and 1.5-2.5 times by mole as much Grignard reagent represented by the general formula (2): R MgX (wherein R represents C2-C10 alkyl having a hydrogen atom at the beta -position; and X represents halogeno).
摘要翻译：用于不饱和碳 - 碳键之间的反应的钛催化剂和具有亲电子官能团或亲电子剂的化合物，该催化剂包含由通式（1）表示的钛化合物：TiX 1 X 2 X 3 X 4（其中X 1，X 2，X 3和X 4各自独立地表示卤代，C 1 -C 20烷氧基，芳烷氧基，芳氧基或-NR x R y（其中R x 和R 3各自独立地表示C1-C20烷基或芳烷基），或者X 1，X 2，X 3和X 4中的任一个可以与它们中的另一个一起形成环） 2.5倍摩尔的由通式（2）表示的格利雅试剂：R 1 MgX 5（其中R 1表示在β-位具有氢原子的C2-C10烷基; X <5 >表示卤代）。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式